Related references
Note: Only part of the references are listed.TLR9 expression is associated with prognosis in patients with glioblastoma multiforme
Lige Leng et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
Duane A. Mitchell et al.
BLOOD (2011)
Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
Mengxian Zhang et al.
CANCER RESEARCH (2011)
Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design
Yohei Mineharu et al.
CLINICAL CANCER RESEARCH (2011)
Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Jennifer Lohr et al.
CLINICAL CANCER RESEARCH (2011)
Gene Therapy and Targeted Toxins for Glioma
Maria G. Castro et al.
CURRENT GENE THERAPY (2011)
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma
Collin Jacobs et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
Sabine Mueller et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy
Ciprian Chira et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T. Pallotta et al.
NATURE IMMUNOLOGY (2011)
Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2011)
Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
Camilo E. Fadul et al.
NEURO-ONCOLOGY (2011)
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
Teri N. Kreisl et al.
NEURO-ONCOLOGY (2011)
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri et al.
NEURO-ONCOLOGY (2011)
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors
Derek A. Wainwright et al.
NEURO-ONCOLOGY (2011)
The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
Shoba Amarnath et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
Kajsa Wing et al.
TRENDS IN IMMUNOLOGY (2011)
The NFκB pathway: a therapeutic target in glioblastoma
Lorena Nogueira et al.
ONCOTARGET (2011)
Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
Mengxian Zhang et al.
NEOPLASIA (2011)
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
Chao Wang et al.
BMC CANCER (2010)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Immune Infiltration of Spontaneous Mouse Astrocytomas Is Dominated by Immunosuppressive Cells from Early Stages of Tumor Development
Nhu Nam Tran Thang et al.
CANCER RESEARCH (2010)
被撤回的出版物: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Retracted article. See vol. 21, pg. 2189, 2015)
Jun Wei et al.
CLINICAL CANCER RESEARCH (2010)
Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege
Lei Huang et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
Kevin C. De Braganca et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions
Tony Avril et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Joannes F. M. Jacobs et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme Clinical article
Linna Li et al.
JOURNAL OF NEUROSURGERY (2010)
Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model
Atique U. Ahmed et al.
MOLECULAR THERAPY (2010)
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma
Sandeep Kunwar et al.
NEURO-ONCOLOGY (2010)
Challenges in Clinical Design of Immunotherapy Trials for Malignant Glioma
Cleo E. Rolle et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
Adam D. Cohen et al.
PLOS ONE (2010)
The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma
Derek A. Wainwright et al.
PLOS ONE (2010)
Targeted Toxins in Brain Tumor Therapy
Yan Michael Li et al.
TOXINS (2010)
Short Hairpin RNA-Mediated Fibronectin Knockdown Delays Tumor Growth in a Mouse Glioma Model
Sadhak Sengupta et al.
NEOPLASIA (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
David J. Chung et al.
BLOOD (2009)
Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
M. D. Groves et al.
BRITISH JOURNAL OF CANCER (2009)
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells
Ling-Yuan Kong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
Anne-Marie Bleau et al.
CELL STEM CELL (2009)
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
A. K. M. Ghulam Muhammad et al.
CLINICAL CANCER RESEARCH (2009)
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
Amy B. Heimberger et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Treatment of malignant gliomas with TGF-β2 antisense oligonucleotides
Peter Hau et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy Laboratory investigation
Takeshi Miyazaki et al.
JOURNAL OF NEUROSURGERY (2009)
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H. Sampson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
Wim Maes et al.
NEURO-ONCOLOGY (2009)
Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
Anand Veeravagu et al.
CLINICAL CANCER RESEARCH (2008)
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
Amy B. Heimberger et al.
CLINICAL CANCER RESEARCH (2008)
Regional hypoxia in glioblastoma multiforme quantified with [18F] fluoromisonidazole positron emission tomography before radiotherapy:: Correlation with time to progression and survival
Alexander M. Spence et al.
CLINICAL CANCER RESEARCH (2008)
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
David A. Reardon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
Oliver M. Grauer et al.
JOURNAL OF IMMUNOLOGY (2008)
Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme
Jeffrey J. Olson et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Toll-Like Receptor 9 Mediates CpG Oligonucleotide-Induced Cellular Invasion
Joanna M. Ilvesaro et al.
MOLECULAR CANCER RESEARCH (2008)
Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas
Emily C. Brantley et al.
MOLECULAR CANCER RESEARCH (2008)
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia et al.
LANCET ONCOLOGY (2008)
FIt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits
Gwendalyn D. King et al.
MOLECULAR THERAPY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model
Gwendalyn D. King et al.
NEURO-ONCOLOGY (2008)
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
James F. Curtin et al.
PLOS ONE (2008)
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model
Oliver M. Grauer et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Justin T. Jordan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Angiogenesis in brain tumours
Rakesh K. Jain et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model
Thomas-Toan Tran et al.
NEURO-ONCOLOGY (2007)
CD4+FoxP3+regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo
Oliver M. Grauer et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna M. Ilvesaro et al.
PROSTATE (2007)
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice
Edward Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group
M. Riva et al.
NEUROLOGICAL SCIENCES (2006)
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors
Abdeljabar El Andaloussi et al.
GLIA (2006)
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors
Abdeljabar El Andaloussi et al.
JOURNAL OF NEUROSURGERY (2006)
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity
Melinda A. Merrell et al.
MOLECULAR CANCER RESEARCH (2006)
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
Abdejabar El Andaloussi et al.
NEURO-ONCOLOGY (2006)
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient
E Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13
Edward Rustamzadeh et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain
James F. Curtin et al.
JOURNAL OF IMMUNOLOGY (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents
David A. Reardon et al.
ONCOLOGIST (2006)
Oncolytic viral therapies - the clinical experience
M Aghi et al.
ONCOGENE (2005)
Successful combination of local CpG-ODN and radiotherapy in malignant glioma
YX Meng et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Endothelial/pericyte interactions
A Armulik et al.
CIRCULATION RESEARCH (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells:: An implication for interaction with Helicobacter pylori
B Schmausser et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
AB Heimberger et al.
CLINICAL CANCER RESEARCH (2005)
Human lung cancer cells express functionally active Toll-like receptor 9
D Droemann et al.
RESPIRATORY RESEARCH (2005)
Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
J Seoane et al.
CELL (2004)
A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model
DA Todhunter et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
CJ Wheeler et al.
CLINICAL CANCER RESEARCH (2004)
Inflammatory and anti-glioma effects of an adenovirus expressing human-soluble Fms-like tyrosine kinase 3 ligand (hsFIt3L): Treatment with hsFIt3L inhibits intracranial glioma progression
S Ali et al.
MOLECULAR THERAPY (2004)
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
JH Sampson et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme
E Rustamzadeh et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter
AH Wu et al.
NEURO-ONCOLOGY (2003)
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
A Salmaggi et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumors
H Huang et al.
CELLULAR IMMUNOLOGY (2002)
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2002)
IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein
BH Joshi et al.
BRITISH JOURNAL OF CANCER (2002)
Pericytes: Cell biology and pathology
G Allt et al.
CELLS TISSUES ORGANS (2001)
Effective treatment of experimental glioblastoma by HSV vector-mediated TNFα and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration
A Niranjan et al.
MOLECULAR THERAPY (2000)
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
AB Heimberger et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)